Tivic Health Systems, Inc. (TIVC)

US — Healthcare Sector
Peers: TLIS  BJDX  HSCS  NUWE  BBLG  INVO  TNON  MOTS  VVOS  RPID  SINT  RSLS  RMED  NAOV 

Automate Your Wheel Strategy on TIVC

With Tiblio's Option Bot, you can configure your own wheel strategy including TIVC - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.

Start Your Free Trial Now

Key Metrics & Ratings

  • symbol TIVC
  • Rev/Share 0.8652
  • Book/Share 5.0908
  • PB 0.8113
  • Debt/Equity 0.0
  • CurrentRatio 1.7018
  • ROIC -1.888

 

  • MktCap 3504474.0
  • FreeCF/Share -8.2969
  • PFCF -0.7083
  • PE -0.4339
  • Debt/Assets 0.0
  • DivYield 0
  • ROE -1.8023

 

  • Rating C-
  • Score 1
  • Recommendation Strong Sell
  • P/E Score 1
  • DCF Score 1
  • P/B Score 4
  • D/E Score 1

Recent Analyst Ratings

Type Ticker Analyst Firm Previous Rating Current Rating Previous Price Target Current Price Target Date
No ratings available.

News

Tivic Health Systems Inc. (TIVC) Q1 2025 Earnings Call Transcript
TIVC
Published: May 15, 2025 by: Seeking Alpha
Sentiment: Neutral

Tivic Health Systems Inc. (NASDAQ:TIVC ) Q1 2025 Earnings Conference Call May 15, 2025 4:30 PM ET Company Participants Jennifer Ernst – Chief Executive Officer Lisa Wolf – Interim Chief Financial Officer Michael Handley – Chief Operating Officer and President-Tivic Biopharma Division Conference Call Participants Operator Welcome to Tivic Health Systems First Quarter 2025 Financial Results and Operational Update Conference Call. This call has been prerecorded, and the questions you have submitted in advance will be answered following the prepared remarks.

Read More
image for news Tivic Health Systems Inc. (TIVC) Q1 2025 Earnings Call Transcript
Tivic Health to Report First Quarter 2025 Financial Results on May 15th Via Conference Call and Webcast
TIVC
Published: May 09, 2025 by: Business Wire
Sentiment: Neutral

FREMONT, Calif.--(BUSINESS WIRE)--Tivic Health® Systems, Inc. (Nasdaq: TIVC), a diversified therapeutics company harnessing the power of the immune and autonomic nervous systems to fight disease and restore health, today announced that it will report its first quarter results for 2025 via pre-recorded conference call and webcast on Thursday, May 15, 2025 at 1:30 PM PT / 4:30 PM ET. Teleconference Details: Toll Free: 1-877-407-0779 International: 1-201-389-0914 Conference ID: 13753498 Webcast Li.

Read More
image for news Tivic Health to Report First Quarter 2025 Financial Results on May 15th Via Conference Call and Webcast

About Tivic Health Systems, Inc. (TIVC)

  • IPO Date 2021-11-11
  • Website https://www.tivichealth.com
  • Industry Medical - Devices
  • CEO Ms. Jennifer Ernst
  • Employees 7

Tivic Health Systems Inc. operates as a bioelectronic device company that delivers non-invasive neuromodulation products for the treatment of inflammatory conditions. Its primary product is ClearUP, is a medical device intended to relieve sinus and nasal inflammation. The company sells its products on direct-to-consumer channel through its own websites; and platforms, such as Amazon.com and Walmart.com, as well as to U.S. online retailers, including BestBuy.com and FSAStore.com. Tivic Health Systems, Inc. was incorporated in 2016 and is headquartered in Hayward, California.